PAM
Panagora Asset Management’s Kezar Life Sciences KZR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-233,206
| Closed | -$210K | – | 1250 |
|
|
2024
Q1 | $210K | Buy |
233,206
+149,119
| +177% | +$134K | ﹤0.01% | 1150 |
|
|
2023
Q4 | $79.7K | Buy |
+84,087
| New | +$79.7K | ﹤0.01% | 1207 |
|
|
2021
Q3 | – | Sell |
-1,689
| Closed | -$9K | – | 2067 |
|
|
2021
Q2 | $9K | Sell |
1,689
-78
| -4% | -$416 | ﹤0.01% | 2298 |
|
|
2021
Q1 | $11K | Hold |
1,767
| – | – | ﹤0.01% | 2384 |
|
|
2020
Q4 | $9K | Sell |
1,767
-972
| -35% | -$4.95K | ﹤0.01% | 2314 |
|
|
2020
Q3 | $13K | Sell |
2,739
-3,018
| -52% | -$14.3K | ﹤0.01% | 2283 |
|
|
2020
Q2 | $30K | Hold |
5,757
| – | – | ﹤0.01% | 2079 |
|
|
2020
Q1 | $25K | Buy |
5,757
+4,683
| +436% | +$20.3K | ﹤0.01% | 1998 |
|
|
2019
Q4 | $4K | Buy |
+1,074
| New | +$4K | ﹤0.01% | 2286 |
|